InsidersTradesSigma
Follow the 삼아제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼아제약 has logged 13 insider filings. The latest transaction was reported on 25 August 2025 (Purchase). Among the most active insiders: 황종숙. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
13 of 13 declarations
Samah Pharmaceutical es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos. Cotiza en el XKRX.